rs200602896

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000719.7(CACNA1C):​c.618G>A​(p.Gly206Gly) variant causes a splice region, synonymous change. The variant allele was found at a frequency of 0.0000633 in 1,610,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000046 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 splice_region, synonymous

Scores

2
Splicing: ADA: 0.7660
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 6.84

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 12-2457567-G-A is Benign according to our data. Variant chr12-2457567-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136611.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00023 (35/152192) while in subpopulation AMR AF = 0.00164 (25/15282). AF 95% confidence interval is 0.00114. There are 0 homozygotes in GnomAd4. There are 27 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 35 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.708G>A p.Gly236Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.618G>A p.Gly206Gly splice_region_variant, synonymous_variant Exon 5 of 46 ENSP00000507309.1
CACNA1CENST00000682152.1 linkc.567G>A p.Gly189Gly splice_region_variant, synonymous_variant Exon 4 of 6 ENSP00000506759.1
CACNA1CENST00000480911.6 linkn.618G>A splice_region_variant, non_coding_transcript_exon_variant Exon 5 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152192
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000893
AC:
22
AN:
246334
AF XY:
0.000112
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000506
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.0000178
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.0000459
AC:
67
AN:
1458608
Hom.:
0
Cov.:
30
AF XY:
0.0000551
AC XY:
40
AN XY:
725518
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33304
American (AMR)
AF:
0.000361
AC:
16
AN:
44304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26042
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39536
South Asian (SAS)
AF:
0.0000350
AC:
3
AN:
85660
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53364
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000324
AC:
36
AN:
1110452
Other (OTH)
AF:
0.000116
AC:
7
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152192
Hom.:
0
Cov.:
33
AF XY:
0.000363
AC XY:
27
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41450
American (AMR)
AF:
0.00164
AC:
25
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68030
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000107
Hom.:
0
Bravo
AF:
0.000291
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000219
EpiControl
AF:
0.00

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 24, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 11, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CACNA1C c.618G>A (p.Gly206Gly) alters a conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8.9e-05 in 246334 control chromosomes (gnomAD), predominantly at a frequency of 0.00051 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 51 fold of the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing the Timothy Syndrome phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. To our knowledge, no occurrence of c.618G>A in individuals affected with Timothy Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter has assessed the variant since 2014: the variant was classified as likely benign. Based on the evidence outlined above, the variant was classified as benign. -

not provided Benign:2
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1C: BP4 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

CACNA1C-related disorder Benign:1
Aug 24, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Long QT syndrome Benign:1
Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Nov 14, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
CADD
Benign
20
DANN
Benign
0.96
PhyloP100
6.8

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.77
dbscSNV1_RF
Benign
0.51
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200602896; hg19: chr12-2566733; API